title: [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].
authors.forename: I
authors.initials: I
authors.lastname: Lahbabi
authors.forename: H
authors.initials: H
authors.lastname: Adamski
authors.forename: S
authors.initials: S
authors.lastname: Le Jean
authors.forename: V
authors.initials: V
authors.lastname: Cannieux
authors.forename: E
authors.initials: E
authors.lastname: Polard
authors.forename: J
authors.initials: J
authors.lastname: Chevrant-Breton
mesh_terms: D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept